Published in World J Surg on August 01, 2011
Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature (2008) 75.40
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med (2004) 71.08
The consensus coding sequences of human breast and colorectal cancers. Science (2006) 60.02
The complete genome of an individual by massively parallel DNA sequencing. Nature (2008) 52.81
The genomic landscapes of human breast and colorectal cancers. Science (2007) 38.12
Wnt/beta-catenin signaling in development and disease. Cell (2006) 30.09
Somatic mutations affect key pathways in lung adenocarcinoma. Nature (2008) 30.02
Untangling the ErbB signalling network. Nat Rev Mol Cell Biol (2001) 28.05
Lessons from hereditary colorectal cancer. Cell (1996) 25.73
Cancer genes and the pathways they control. Nat Med (2004) 24.22
Characterizing the cancer genome in lung adenocarcinoma. Nature (2007) 16.48
Functional interaction of beta-catenin with the transcription factor LEF-1. Nature (1996) 15.88
The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell (2002) 13.92
XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos. Cell (1996) 11.70
Identification of FAP locus genes from chromosome 5q21. Science (1991) 11.41
Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science (1991) 9.89
Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial. Lancet (2009) 8.73
Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet (2004) 7.78
EGFR and cancer prognosis. Eur J Cancer (2001) 7.52
CpG island methylator phenotype in cancer. Nat Rev Cancer (2004) 7.13
A new member of the frizzled family from Drosophila functions as a Wingless receptor. Nature (1996) 7.04
LDL-receptor-related proteins in Wnt signal transduction. Nature (2000) 6.94
Notch signaling controls multiple steps of pancreatic differentiation. Proc Natl Acad Sci U S A (2003) 6.55
An LDL-receptor-related protein mediates Wnt signalling in mice. Nature (2000) 6.34
A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation. Nature (2005) 5.50
Casein kinase 1 gamma couples Wnt receptor activation to cytoplasmic signal transduction. Nature (2005) 4.88
The ABC of APC. Hum Mol Genet (2001) 4.16
SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor. J Biol Chem (2005) 4.13
Beta-catenin mutations in cell lines established from human colorectal cancers. Proc Natl Acad Sci U S A (1997) 3.79
Familial adenomatous polyposis. Am J Gastroenterol (2006) 3.77
Signaling cross-talk between TGF-beta/BMP and other pathways. Cell Res (2009) 3.66
Oncogenic PI3K and its role in cancer. Curr Opin Oncol (2006) 3.61
Identification of pathways regulating cell size and cell-cycle progression by RNAi. Nature (2006) 3.60
Interaction between Wnt and TGF-beta signalling pathways during formation of Spemann's organizer. Nature (2000) 3.35
Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling. Nat Genet (2000) 3.33
The epidermal growth factor receptor pathway: a model for targeted therapy. Clin Cancer Res (2006) 3.17
Pten constrains centroacinar cell expansion and malignant transformation in the pancreas. Cancer Cell (2005) 3.15
Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors. Cancer Res (1995) 3.04
Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res (2000) 2.99
Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways. Proc Natl Acad Sci U S A (2000) 2.97
The 'just-right' signaling model: APC somatic mutations are selected based on a specific level of activation of the beta-catenin signaling cascade. Hum Mol Genet (2002) 2.69
Regulation of signal transduction and signal diversity by receptor oligomerization. Trends Biochem Sci (1994) 2.38
WNT/PCP signaling pathway and human cancer (review). Oncol Rep (2005) 2.17
The Wnt antagonist sFRP1 in colorectal tumorigenesis. Cancer Res (2004) 2.16
A genome-wide RNAi screen for Wnt/beta-catenin pathway components identifies unexpected roles for TCF transcription factors in cancer. Proc Natl Acad Sci U S A (2008) 2.10
Four human ras homologs differ in their abilities to activate Raf-1, induce transformation, and stimulate cell motility. J Biol Chem (1999) 1.99
Monoclonal antibodies to target epidermal growth factor receptor-positive tumors: a new paradigm for cancer therapy. Cancer (2002) 1.97
EGF mutant receptor vIII as a molecular target in cancer therapy. Endocr Relat Cancer (2001) 1.97
Oncogenic beta-catenin is required for bone morphogenetic protein 4 expression in human cancer cells. Cancer Res (2002) 1.82
Smad4 and beta-catenin co-activators functionally interact with lymphoid-enhancing factor to regulate graded expression of Msx2. J Biol Chem (2003) 1.77
Persistent expression of PDX-1 in the pancreas causes acinar-to-ductal metaplasia through Stat3 activation. Genes Dev (2006) 1.76
Control of the ERK MAP kinase cascade by Ras and Raf. Cancer Surv (1996) 1.74
The beta cell transcription factors and development of the pancreas. J Mol Med (Berl) (1997) 1.73
Primary structure and tissue distribution of FRZB, a novel protein related to Drosophila frizzled, suggest a role in skeletal morphogenesis. J Biol Chem (1996) 1.70
Functional, persistent, and extended liver to pancreas transdifferentiation. J Biol Chem (2003) 1.70
Predictive value of EGFR and HER2 overexpression in advanced non-small-cell lung cancer. Oncogene (2009) 1.67
Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer. Cancer Res (1996) 1.59
A monoclonal antibody against Wnt-1 induces apoptosis in human cancer cells. Neoplasia (2004) 1.54
A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential. Gastroenterology (2009) 1.52
Sequence variants of the axin gene in breast, colon, and other cancers: an analysis of mutations that interfere with GSK3 binding. Genes Chromosomes Cancer (2000) 1.52
Epithelial Pten is dispensable for intestinal homeostasis but suppresses adenoma development and progression after Apc mutation. Nat Genet (2008) 1.50
Hedgehog signaling pathway and gastrointestinal stem cell signaling network (review). Int J Mol Med (2006) 1.49
Expression of somatostatin receptor subtype 1-5 genes in human pancreatic cancer. J Natl Cancer Inst (1998) 1.45
Pdx1 level defines pancreatic gene expression pattern and cell lineage differentiation. J Biol Chem (2001) 1.42
Genetic pathways to glioblastomas. Neuropathology (2005) 1.41
In vitro transdifferentiation of mature hepatocytes into insulin-producing cells. Endocr J (2006) 1.39
The role of hepatic nuclear factor 1 alpha and PDX-1 in transcriptional regulation of the pdx-1 gene. J Biol Chem (2001) 1.35
Promoter methylation of the Wnt/beta-catenin signaling antagonist Dkk-3 is associated with poor survival in gastric cancer. Cancer (2009) 1.32
Exon 3 beta-catenin mutations are specifically associated with colorectal carcinomas in hereditary non-polyposis colorectal cancer syndrome. Gut (2005) 1.29
Pancreas duodenum homeobox-1 regulates pancreas development during embryogenesis and islet cell function in adulthood. Eur J Endocrinol (2002) 1.28
Hedgehog signaling pathway is essential for pancreas specification in the zebrafish embryo. Curr Biol (2001) 1.24
Characterization of pancreatic transcription factor Pdx-1 binding sites using promoter microarray and serial analysis of chromatin occupancy. J Biol Chem (2007) 1.21
OPG is regulated by beta-catenin and mediates resistance to TRAIL-induced apoptosis in colon cancer. Clin Cancer Res (2008) 1.20
PDX-1 acts as a potential molecular target for treatment of human pancreatic cancer. Pancreas (2008) 1.17
Increased PDX-1 expression is associated with outcome in patients with pancreatic cancer. Surgery (2003) 1.14
Expression of Pdx-1 in human gastric metaplasia and gastric adenocarcinoma. Hum Pathol (2006) 1.14
sst2 somatostatin receptor expression reverses tumorigenicity of human pancreatic cancer cells. Cancer Res (1997) 1.12
PDX-1 and the pancreas. Pancreas (2004) 1.11
Involvement of the homeodomain-containing transcription factor PDX-1 in islet amyloid polypeptide gene transcription. Biochem Biophys Res Commun (1996) 1.11
The RASSF8 candidate tumor suppressor inhibits cell growth and regulates the Wnt and NF-kappaB signaling pathways. Oncogene (2010) 1.10
Frequent alterations in the Wnt signaling pathway in colorectal cancer with microsatellite instability. Genes Chromosomes Cancer (2002) 1.09
Id-1 activates Akt-mediated Wnt signaling and p27(Kip1) phosphorylation through PTEN inhibition. Oncogene (2008) 1.07
Drosophila split ends homologue SHARP functions as a positive regulator of Wnt/beta-catenin/T-cell factor signaling in neoplastic transformation. Cancer Res (2007) 1.03
Autoregulation and maturity onset diabetes of the young transcription factors control the human PAX4 promoter. J Biol Chem (2000) 1.03
Rational bases for the development of EGFR inhibitors for cancer treatment. Int J Biochem Cell Biol (2007) 1.02
PDX1 homeobox protein expression in pseudopyloric glands and gastric carcinomas. Gut (2004) 1.02
The Wnt antagonist sFRP1 is downregulated in premalignant large bowel adenomas. Br J Cancer (2006) 1.00
Pancreatic and duodenal homeobox gene 1 induces hepatic dedifferentiation by suppressing the expression of CCAAT/enhancer-binding protein beta. Hepatology (2007) 0.98
Tissue MicroArray analyses of pancreatic duodenal homeobox-1 in human cancers. World J Surg (2005) 0.98
Basic principles and technologies for deciphering the genetic map of cancer. World J Surg (2009) 0.96
EGFR targeted therapy in non-small cell lung cancer: potential role of cetuximab. Biologics (2009) 0.95
Pancreas duodenal homeobox-1 expression and significance in pancreatic cancer. World J Gastroenterol (2007) 0.94
Insulin and epidermal growth factor receptors regulate distinct pools of Grb2-SOS in the control of Ras activation. J Biol Chem (1996) 0.94
The expression pattern of PDX-1, SHH, Patched and Gli-1 is associated with pathological and clinical features in human pancreatic cancer. Pancreatology (2008) 0.92
Reexpression of human somatostatin receptor gene 2 gene mediated by oncolytic adenovirus increases antitumor activity of tumor necrosis factor-related apoptosis-inducing ligand against pancreatic cancer. Clin Cancer Res (2009) 0.91
Induction of differentiation of embryonic stem cells into insulin-secreting cells by fetal soluble factors. Stem Cells (2005) 0.91
Mutations of the APC (adenomatous polyposis coli) gene in FAP (familial polyposis coli) patients and in sporadic colorectal tumors. Tohoku J Exp Med (1992) 0.90
Characterization of the bystander effect of somatostatin receptor sst2 after in vivo gene transfer into human pancreatic cancer cells. Hum Gene Ther (2005) 0.90
Cellular plasticity of trans- and dedifferentiation markers in human hepatoma cells in vitro and in vivo. Int J Oncol (2009) 0.89
Somatostatin receptor-1 induces cell cycle arrest and inhibits tumor growth in pancreatic cancer. Cancer Sci (2008) 0.89
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature (2012) 8.31
Chlorhexidine-Alcohol versus Povidone-Iodine for Surgical-Site Antisepsis. N Engl J Med (2010) 8.02
PPM1A functions as a Smad phosphatase to terminate TGFbeta signaling. Cell (2006) 5.28
Association between implementation of a medical team training program and surgical mortality. JAMA (2010) 5.19
Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer. Cancer (2009) 4.12
Perineural invasion in cancer: a review of the literature. Cancer (2009) 3.06
Perineural invasion is an independent predictor of outcome in colorectal cancer. J Clin Oncol (2009) 3.04
Allogeneic granulocyte macrophage colony-stimulating factor-secreting tumor immunotherapy alone or in sequence with cyclophosphamide for metastatic pancreatic cancer: a pilot study of safety, feasibility, and immune activation. Clin Cancer Res (2008) 2.67
Comparison of laparoscopic and open repair with mesh for the treatment of ventral incisional hernia: a randomized trial. Arch Surg (2010) 2.58
Shear stress induces endothelial differentiation from a murine embryonic mesenchymal progenitor cell line. Arterioscler Thromb Vasc Biol (2005) 2.51
Ginseng compounds: an update on their molecular mechanisms and medical applications. Curr Vasc Pharmacol (2009) 2.44
Current advances in research and clinical applications of PLGA-based nanotechnology. Expert Rev Mol Diagn (2009) 2.35
Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis. World J Surg (2009) 2.31
miRNA profiling for diagnosis and prognosis of human cancer. DNA Cell Biol (2007) 2.26
Novel approaches to perioperative assessment and intervention may improve long-term outcomes after colorectal cancer resection in older adults. Ann Surg (2011) 2.16
TNFerade biologic, an adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene: a phase I study in patients with solid tumors. J Clin Oncol (2004) 2.09
Trop2: a possible therapeutic target for late stage epithelial carcinomas. Biochim Biophys Acta (2009) 2.08
siRNA vs. shRNA: similarities and differences. Adv Drug Deliv Rev (2009) 1.91
Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer. Mol Cancer Ther (2008) 1.90
SUMO-1/Ubc9 promotes nuclear accumulation and metabolic stability of tumor suppressor Smad4. J Biol Chem (2003) 1.82
Association between implementation of a medical team training program and surgical morbidity. Arch Surg (2011) 1.82
Aberrant expression of zinc transporter ZIP4 (SLC39A4) significantly contributes to human pancreatic cancer pathogenesis and progression. Proc Natl Acad Sci U S A (2007) 1.81
Clinical and local biological effects of an intratumoral injection of mda-7 (IL24; INGN 241) in patients with advanced carcinoma: a phase I study. Mol Ther (2005) 1.81
Bridging the communication gap in the operating room with medical team training. Am J Surg (2005) 1.80
HIV protease inhibitor ritonavir induces cytotoxicity of human endothelial cells. Arterioscler Thromb Vasc Biol (2002) 1.78
A live-attenuated Listeria vaccine (ANZ-100) and a live-attenuated Listeria vaccine expressing mesothelin (CRS-207) for advanced cancers: phase I studies of safety and immune induction. Clin Cancer Res (2011) 1.78
The role of the tumor microenvironment in the progression of pancreatic cancer. J Surg Res (2008) 1.75
Granulocyte macrophage colony-stimulating factor--secreting allogeneic cellular immunotherapy for hormone-refractory prostate cancer. Clin Cancer Res (2007) 1.71
Obesity increases wound complications in rectal cancer surgery. J Surg Res (2010) 1.69
ZIP4 upregulates the expression of neuropilin-1, vascular endothelial growth factor, and matrix metalloproteases in pancreatic cancer cell lines and xenografts. Cancer Biol Ther (2010) 1.63
Cyclophilin A is overexpressed in human pancreatic cancer cells and stimulates cell proliferation through CD147. Cancer (2006) 1.59
[Clinical and laboratory study of a case of hematidrosis]. Zhonghua Xue Ye Xue Za Zhi (2004) 1.59
Serum response factor is alternatively spliced in human colon cancer. J Surg Res (2004) 1.58
Opposed regulation of corepressor CtBP by SUMOylation and PDZ binding. Mol Cell (2003) 1.57
Prognostic factors for the development of gangrenous cholecystitis. Am J Surg (2003) 1.56
Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma-differentiation associated gene-7 (mda-7/IL24): biologic outcome in advanced cancer patients. Mol Ther (2005) 1.53
Increasing incidence of methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: reconsideration of empiric antimicrobial therapy. Am J Surg (2007) 1.51
Phase I study of oral CI-994 in combination with carboplatin and paclitaxel in the treatment of patients with advanced solid tumors. Cancer Invest (2004) 1.51
Stathmin 1: a novel therapeutic target for anticancer activity. Expert Rev Anticancer Ther (2008) 1.51
Chemical and molecular mechanisms of antioxidants: experimental approaches and model systems. J Cell Mol Med (2009) 1.51
Sphincter preservation rates after radical resection for rectal cancer in the United States veteran population: opportunity for improvement in early disease. Ann Surg Oncol (2014) 1.47
mda-7/IL-24: exploiting cancer's Achilles' heel. Mol Ther (2005) 1.46
Nicotine and cotinine up-regulate vascular endothelial growth factor expression in endothelial cells. Am J Pathol (2002) 1.46
Adipokine resistin promotes in vitro angiogenesis of human endothelial cells. Cardiovasc Res (2006) 1.45
Elevated interleukin-6 and G-CSF in human pancreatic cancer cell conditioned medium suppress dendritic cell differentiation and activation. Cancer Res (2007) 1.43
Spider Bites Presenting with Methicillin-Resistant Staphylococcus aureus Soft Tissue Infection Require Early Aggressive Treatment. Surg Infect (Larchmt) (2003) 1.43
Trop2 expression contributes to tumor pathogenesis by activating the ERK MAPK pathway. Mol Cancer (2010) 1.43
A multidisciplinary cancer center maximizes surgeons' impact. J Surg Res (2011) 1.42
Fighting cancer with vaccinia virus: teaching new tricks to an old dog. Mol Ther (2005) 1.40
MicroRNA and colorectal cancer. World J Surg (2009) 1.40
Lysophosphatidylcholine and secretory phospholipase A2 in vascular disease: mediators of endothelial dysfunction and atherosclerosis. Med Sci Monit (2005) 1.37
Overcoming drug resistance in pancreatic cancer. Expert Opin Ther Targets (2011) 1.36
Activation of transforming growth factor-beta signaling by SUMO-1 modification of tumor suppressor Smad4/DPC4. J Biol Chem (2003) 1.32
Molecular mechanisms of HIV protease inhibitor-induced endothelial dysfunction. J Acquir Immune Defic Syndr (2007) 1.32
Elevated portal vein drug levels of sirolimus and tacrolimus in islet transplant recipients: local immunosuppression or islet toxicity? Transplantation (2003) 1.32
Islet vasculature as a regulator of endocrine pancreas function. World J Surg (2007) 1.31
Down-regulation of ZIP4 by RNA interference inhibits pancreatic cancer growth and increases the survival of nude mice with pancreatic cancer xenografts. Clin Cancer Res (2009) 1.30
Child-Turcotte-Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients. Am J Surg (2004) 1.27
Development of small-diameter vascular grafts. World J Surg (2007) 1.27
Oncolytic viral therapies. Cancer Gene Ther (2004) 1.26
Abdominal wall repair using human acellular dermis. Am J Surg (2007) 1.25
Molecular mechanisms and clinical applications of nordihydroguaiaretic acid (NDGA) and its derivatives: an update. Med Sci Monit (2010) 1.24
Infectious postoperative complications decrease long-term survival in patients undergoing curative surgery for colorectal cancer: a study of 12,075 patients. Ann Surg (2015) 1.23
Enhancement of surgical informed consent by addition of repeat back: a multicenter, randomized controlled clinical trial. Ann Surg (2010) 1.23
Pancreatic carcinoma cells express neuropilins and vascular endothelial growth factor, but not vascular endothelial growth factor receptors. Cancer (2004) 1.22
General surgery as a career: a contemporary review of factors central to medical student specialty choice. J Am Coll Surg (2004) 1.22
Resistin: functional roles and therapeutic considerations for cardiovascular disease. Br J Pharmacol (2012) 1.22
Polymer nanofiber-embedded microchips for detection, isolation, and molecular analysis of single circulating melanoma cells. Angew Chem Int Ed Engl (2013) 1.21
Mesothelin overexpression promotes autocrine IL-6/sIL-6R trans-signaling to stimulate pancreatic cancer cell proliferation. Carcinogenesis (2011) 1.20
Minimally invasive surgery is underutilized for colon cancer. Ann Surg Oncol (2011) 1.19
Laparoscopic colon resection early in the learning curve: what is the appropriate setting? Ann Surg (2006) 1.19
Ceramide: a common pathway for atherosclerosis? Atherosclerosis (2007) 1.19
EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic cancer: a phase I/II study. Gastrointest Endosc (2012) 1.19
Mesothelin-induced pancreatic cancer cell proliferation involves alteration of cyclin E via activation of signal transducer and activator of transcription protein 3. Mol Cancer Res (2008) 1.19
Oncolytic viruses for induction of anti-tumor immunity. Curr Pharm Biotechnol (2012) 1.18
PDX-1 acts as a potential molecular target for treatment of human pancreatic cancer. Pancreas (2008) 1.17
Human immunodeficiency virus protease inhibitor ritonavir inhibits cholesterol efflux from human macrophage-derived foam cells. Am J Pathol (2007) 1.17
A prospective evaluation of hypogastric artery embolization in endovascular aortoiliac aneurysm repair. J Vasc Surg (2002) 1.16
GM-CSF gene-transduced tumor vaccines. Mol Ther (2005) 1.16
Effects of adipocyte-derived cytokines on endothelial functions: implication of vascular disease. J Surg Res (2005) 1.16
Mesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression. Mol Cancer (2011) 1.16
Virus-like particle (VLP) lymphatic trafficking and immune response generation after immunization by different routes. J Immunother (2009) 1.16
Does resident hours reduction have an impact on surgical outcomes? J Surg Res (2005) 1.16
Current update on HIV-associated vascular disease and endothelial dysfunction. World J Surg (2007) 1.15
Expression and function of a large non-coding RNA gene XIST in human cancer. World J Surg (2011) 1.15
Phase I trial of "bi-shRNAi(furin)/GMCSF DNA/autologous tumor cell" vaccine (FANG) in advanced cancer. Mol Ther (2011) 1.15
Roles of cyclophilins in cancers and other organ systems. World J Surg (2005) 1.14
Smad6 recruits transcription corepressor CtBP to repress bone morphogenetic protein-induced transcription. Mol Cell Biol (2003) 1.13
ZIP4 regulates pancreatic cancer cell growth by activating IL-6/STAT3 pathway through zinc finger transcription factor CREB. Clin Cancer Res (2010) 1.13
MicroRNAs: control and loss of control in human physiology and disease. World J Surg (2009) 1.12
Melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24): novel gene therapeutic for metastatic melanoma. Toxicol Appl Pharmacol (2006) 1.12
Impact of three-dimensional vision in laparoscopic training. World J Surg (2008) 1.12
RNA interference and cancer therapy. Pharm Res (2011) 1.11
PDX-1 and the pancreas. Pancreas (2004) 1.11
Small interfering RNA therapy in cancer: mechanism, potential targets, and clinical applications. Expert Opin Ther Targets (2008) 1.11